SurvivorshipNCT07871773
Food Is Medicine In Survivorship (Foodiis-AYA): Examining The Feasibility And Acceptability Of A Remotely-Delivered Meal Kit And Culinary Medicine Program For Survivors Of Adolescent/Young Adult (AYA) Cancer
A study testing Meal Preps and Questionnaire in people with Survivorship and Meal Kit, run by M.D. Anderson Cancer Center at 1 site in United States.
Trial summary
To study the feasibility of a new nutritional intervention (Food is Medicine in Survivorship - Adolescents / Young Adults [FoodiiSAYA]) for patients 18-25 years old who have completed cancer treatment. Read more about this study
- Who is it for?
- Ages 18 to 25 years
- Conditions the study is for
- Survivorship, Meal Kit, Culinary Medicine
- What is being tested?
- Meal Preps and Questionnaire
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 15 participants
- Where
- 1 siteUnited States
- Study dates
- 16 Mar 2027to 31 Jul 2027
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 25 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
None listed.
Who cannot join
- Individuals under 18 or over 25 years old at the time of study enrollment
- Currently undergoing active cancer treatment for recurrent or new primary cancer
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
UT MD Anderson Cancer Center
Houston, Texas, 77030
Margaret Raber, DrPH, 713-563-8768, MPRaber@mdanderson.org
Margaret Raber, DrPH
About this study
To study the feasibility of a new nutritional intervention (Food is Medicine in Survivorship - Adolescents / Young Adults [FoodiiSAYA]) for patients 18-25 years old who have completed cancer treatment.
Read the detailed description
Primary Objectives To examine the feasibility of FoodiiS-AYA, a scalable Food is Medicine intervention including brief digital culinary medicine education and healthy meal kit delivery targeting AYA cancer survivors aged 18-25 years.
- Conditions
- Survivorship, Meal Kit, Culinary Medicine
- Being tested
- Meal Preps, Questionnaire
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Meal PrepsOther
You will have a meal kit delivered to your home every month (Weeks 1, 5, and 9) during the 3-month program period. Each kit will include ingredients for making a healthy, nutritious meal.
QuestionnaireOther
You will be asked to complete another series of questionnaires. These will include several of the questionnaires you filled out at baseline, along with another short survey
| Study group | Role | What they receive |
|---|---|---|
| Foodiis Intervention | Experimental | Intervention includes videos, recipes, and other online healthy eating content. Receives: Other: Meal Preps; Other: Questionnaire |
What is being measured
The primary outcome is the main question the study is designed to answer.
Safety and adverse events (AEs)
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
Measured: Through study completion; an average of 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Oct 2026
- Study start16 Mar 2027 (estimated)
- Primary completion31 Jul 2027 (estimated)
- Study completion31 Jul 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SurvivorshipStudies of the same condition, open and under way.
- More trials run by M.D. Anderson Cancer CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 15 participants (estimated)
Sponsor and investigators
- Lead sponsor
- M.D. Anderson Cancer Center
- Sponsor type
- University, hospital or other
- Collaborators
- Cancer Prevention Research Institute of Texas
- Responsible party
- Sponsor
- Investigators
- Margaret Raber, DrPH, Principal investigator, UT MD Anderson Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07871773
- Sponsor's protocol ID
- 2026-1039
- Other IDs
- NCI-2026-07500
- Status last verified
- Oct 2026
- First submitted
- 7 Oct 2026
- Last updated
- 13 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No